U
Decision Diagnostics Corp. DECN
$0.00 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
D
Sell 5/5/2022Upgraded
Decision Diagnostics Corp. (DECN) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index.
D
Sell 4/20/2022Downgrade
Decision Diagnostics Corp. (DECN) was downgraded to D- from D on 4/20/2022 due to a large decline in the solvency index and total return index. The quick ratio declined from 0.27 to 0.22.
D
Sell 11/23/2021Upgraded
Decision Diagnostics Corp. (DECN) was upgraded to D from D- on 11/23/2021.
D
Sell 11/8/2021Downgrade
Decision Diagnostics Corp. (DECN) was downgraded to D- from D on 11/8/2021 due to a decline in the total return index and growth index.
D
Sell 9/20/2021Upgraded
Decision Diagnostics Corp. (DECN) was upgraded to D from D- on 9/20/2021 due to a significant increase in the valuation index.
D
Sell 8/9/2021Downgrade
Decision Diagnostics Corp. (DECN) was downgraded to D- from D on 8/9/2021 due to a significant decline in the valuation index and total return index.
D
Sell 7/20/2021Upgraded
Decision Diagnostics Corp. (DECN) was upgraded to D from D- on 7/20/2021 due to a significant increase in the valuation index.
D
Sell 6/11/2021Downgrade
Decision Diagnostics Corp. (DECN) was downgraded to D- from D on 6/11/2021 due to a significant decline in the total return index, growth index and volatility index. EBIT declined 30.91% from -$346.8 to -$454.
D
Sell 5/1/2020Upgraded
Decision Diagnostics Corp. (DECN) was upgraded to D from D- on 5/1/2020 due to an increase in the total return index.
D
Sell 4/21/2020Upgraded
Decision Diagnostics Corp. (DECN) was upgraded to D- from E+ on 4/21/2020 due to a major increase in the solvency index and total return index.
E
Sell 4/6/2020Downgrade
Decision Diagnostics Corp. (DECN) was downgraded to E+ from D- on 4/6/2020 due to a significant decline in the solvency index, growth index and valuation index. Debt to equity increased from 0.51 to 36.18, earnings per share declined from -$0.002 to -$0.0135, and operating cash flow declined 279.04% from -$22.9 to -$86.8.
D
Sell 3/27/2020Downgrade
Decision Diagnostics Corp. (DECN) was downgraded to D- from D on 3/27/2020 due to a decline in the valuation index.
D
Sell 3/12/2020Upgraded
Decision Diagnostics Corp. (DECN) was upgraded to D from D- on 3/12/2020 due to a substantial increase in the growth index, solvency index and valuation index. Operating cash flow increased 94.38% from -$407.3 to -$22.9, and EBIT increased 25.31% from -$382.8 to -$285.9.
D
Sell 6/3/2019Upgraded
Decision Diagnostics Corp. (DECN) was upgraded to D- from E+ on 6/3/2019 due to an increase in the volatility index.
E
Sell 5/17/2019Downgrade
Decision Diagnostics Corp. (DECN) was downgraded to E+ from D- on 5/17/2019 due to a noticeable decline in the solvency index, valuation index and efficiency index. Debt to equity increased from 1.09 to 4.78, net income declined 71.12% from -$735.4 to -$1.26M, and total capital declined 27.8% from $2.85M to $2.06M.
D
Sell 3/4/2019Downgrade
Decision Diagnostics Corp. (DECN) was downgraded to D- from D on 3/4/2019 due to a significant decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.94 to 1.09, and the quick ratio declined from 0.51 to 0.48.
Weiss Ratings